Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial

BACKGROUND: In a randomized phase II trial conducted in patients with metastatic melanoma, patient-specific autologous dendritic cell vaccines (DCV) were associated with longer survival than autologous tumor cell vaccines (TCV). Both vaccines presented antigens from cell-renewing autologous tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Nistor, Gabriel I., Dillman, Robert O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171762/
https://www.ncbi.nlm.nih.gov/pubmed/32316978
http://dx.doi.org/10.1186/s12967-020-02328-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171762/
https://www.ncbi.nlm.nih.gov/pubmed/32316978
http://dx.doi.org/10.1186/s12967-020-02328-6

Ejemplares similares